商业健康险近10年保费年均复合增长率超20%

Core Insights - The commercial health insurance sector in China is experiencing significant growth driven by policy support and market demand, with a compound annual growth rate (CAGR) of over 20% in premium income over the past decade [1][2] - The industry is transitioning from a focus on scale expansion to quality improvement, evolving from "single product competition" to "ecosystem competition" [1][2] Industry Growth and Structure - The commercial health insurance market has over 11,000 medical insurance products available, providing robust support for public health [1] - The core offerings of commercial health insurance include critical illness insurance and medical insurance, with critical illness insurance seeing a slowdown in growth while medical insurance, particularly short-term plans, is rapidly expanding [2][3] - In the first 11 months of 2025, health insurance premium income from life insurance companies was 725.2 billion yuan, showing a slight decline compared to the same period in 2024, while property insurance companies reported a premium income of 218.7 billion yuan from short-term medical insurance, marking an 11.4% year-on-year increase [2] Quality Improvement Initiatives - The industry is focusing on enhancing product pricing and risk matching to solidify its foundation for high-quality development [4] - The China Banking and Insurance Information Technology Management Co. is working on optimizing health insurance product inspections and integrating medical insurance data to strengthen regulatory effectiveness [4] - The China Actuarial Society is developing net cost tables for commercial medical insurance to improve the alignment of insurance pricing with underwriting risks [4][5] Investment Strategies - The insurance sector is actively investing in the healthcare and elderly care industries, with over 150 billion yuan directed towards medical-related investments by the end of 2025 [6] - Direct investments in healthcare and elderly care reached nearly 30 billion yuan, covering various sectors such as biotechnology and medical devices [6] - Indirect investments in healthcare-related funds exceeded 250 billion yuan, indicating a strong commitment to the health sector [6] Future Outlook - The commercial health insurance industry is expected to integrate more deeply into the "Healthy China" strategy, evolving from a passive payer to an active health manager [7] - The focus will be on data-driven approaches and product innovation to address gaps in coverage for the elderly and those with pre-existing conditions, while also supporting the development of new biopharmaceuticals [7]